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Abstract 
Consumption of drugs of abuse is a scourge of modern world. Abuse, drug addiction and their 
consequences are one of the major current problems of European society because of the significant 
repercussions in individual, family, social and economic level. In this context, toxicological analysis of 
the drugs of abuse in biological samples is a useful tool for: diagnosis of drug addiction, checking an 
auto-response, mandatory screening in some treatment programs, identification of a substance in the 
case of an overdose, determining compliance of the treatment. 
The present paper aims to address the needs of healthcare professionals involved in drugs 
addiction treatment through systematic presentation of information regarding their toxicological 
analysis. Basically, it is a tool that help you to select the suitable biological sample and the right 
collecting time, as well as the proper analysis technique, depending on the purpose of analysis, 
pharmacokinetic characteristics of the drugs of abuse, available equipment and staff expertise. 
 
JMMS 2015, 2(2): 108- 127. Review 
 Toxicological analysis for drugs abuse 
 
109 
 
Introduction 
Consumption of drugs of abuse is a scourge of modern world, regardless the fact that we are 
talking about high-risk drugs or about the off label use of certain authorized medicinal products. It is a 
large-scale, multifactorial, dynamic phenomenon which affects all the age groups, but predominantly the 
one between 14 and 35 years old. Abuse and drug addiction, as well as their consequences are one of the 
major problems in the current European society (1- 3). This is due to their significant repercussions in 
individual, family and social level (crime, social marginalization, and death due to overdose or by 
suicide) as well as in the economic level: dependence treatment costs but also the costs of the therapy for 
viral and bacterial infections associated with the intravenous consumption (AIDS, HVC, or reappearance 
of TBC) (4, 5). Given the major risks associated with the drugs of abuse, their analysis in biological 
samples is a useful tool for: 
- Initial diagnosis of drug addiction  
- Checking an auto-response, a declaration 
- Mandatory screening in some treatment programs 
- Screening as a method of tracking drug effects over time 
- Identification of the substance in case of an overdose 
- Determination of treatment compliance 
 
Discussion 
Toxicological analysis represents the whole analytical processes through which the presence of a 
toxic substance in an analysed sample is determined. It includes the physicochemical methods for the 
isolation, identification and quantification of toxic substances in the air, water, soil, food, delict objects 
and organic products for the prevention or diagnosis of intoxications (6- 9). 
Drugs of abuse are those substances which, as a result of pleasant effects they produce, are used 
for other purposes than the ones they are intended to. For example, the therapeutic effect in the 
 Toxicological analysis for drugs abuse 
 
110 
 
benzodiazepines case or the industrial use in volatile solvents case. Drugs of abuse are those substances 
whose possession, transport or storage is restricted by law, due to potential harmful effect on the 
consumer and include materials manufactured under license, as well as illicit products manufactured in 
clandestine laboratories or natural products (10- 14).  
The methodology of toxicological analyses of drugs of abuse is developed based on: 
- Type of sample used 
- Scope of analysis 
- Pharmacokinetic features and biotransformation of the illicit substance 
- Available equipment and reagents 
- Staff expertise 
- Costs. 
Biological samples. Depending on the purpose of the analysis, the substances of abuse may be 
determined from different biological samples.  
Blood/plasma: first choice for the quantitative determination of drugs; therapeutic levels in the blood 
are low but, when they are consumed abusively, the concentrations may be 2-3 times higher. 
Urine: first choice for screening of drugs of abuse. It is available in sufficient quantity and substances or 
metabolites are present in relatively high concentrations. 
Hair: it is used for the determination of the history of an abuse substance consumption. Detection is 
possible at10-14 days to 90 days after ingestion. 
Saliva: it is used for the screening of drugs of abuse consumed within the last 24 hours.  
Meconium: reveals maternal history of drugs of abuse consumption in the last 20 weeks of pregnancy 
and allow the choice of therapy for mother and new-born. 
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Breast milk: it is used for the determination of the exposure extent of the infant to drugs of abuse.  
For example, in table no. 1 are presented the chromatographic techniques used for the analysis of 
methadone cited in the literature, grouped according to biological samples in which the determination is 
carried out (15- 16). 
Table 1. Chromatographic analysis of methadone according to the biological samples 
BIOLOGICAL 
SAMPLE 
GC-MS HPLC LC-MS 
Plasma   
Schmidt N. et al.,1992 
Foster D. et al, 2001 
Foster D. et al, 2003 
Hallinan R. et al, 2006 
Liang H.R. et al., 2004 
Whittington D. et al., 2004 
Etter M.L. et al., 2005 
Lehotay D.C. et al., 2005 
Rook E.J. et al., 2005 
Quintela O. et al., 2006 
Jenkins R. et al., 2006 
Shakleya D.M. et al, 2007 
Urine 
Larson M. et al, 2009 
Moore C. et al., 2001 
Cheng Y.-F. et al., 1999 
Dams R. et al, 2003 
Shakleya D.M. et al, 2010 
Breast milk     
Choo R.E. et al, 2007 
Jansson L.M. et al, 2007 
Meconium     Choo R. E. et al, 2005 
Umbilical cord Nikolaou P.D. et al., 2008   de Castro A. et al., 2009 
Placenta   Nanovskaya T.N. et al., 2004   
Saliva     
Concheiro M. et al, 2010 
Rodriguez Rosasa M.E. et al., 
2003 
Ortelli D. et al., 2000 
Hair 
Moeller M.R. et al., 1993 
Lucas A.C.S. et al., 2000 
Girod C. et al., 2001 
  Kintz P. et al., 2009 
Sweating Brunet B.R. et al., 2008     
 
The detection time of abuse substances is varying in different biological samples. For example, 
drugs of abuse are detected in saliva within minutes after consumption and in urine only after 4-8 hours 
(17- 19).  
Biological samples matrix is very complex and contains other endogenous or exogenous 
substances in addition to substances of interest. This is the reason that, in most cases, is necessary to use 
specific isolation procedures (20- 24). 
 Toxicological analysis for drugs abuse 
 
112 
 
Table 2. The detection time of certain substances of abuse in saliva and urine 
Abuse substance Saliva Urine 
Marijuana 12-24 hours Days/wk. Depending on the frequency of use 
Opioid 12-24 hours 2-4 days 
Amphetamine 24-48 hours 1-2 days 
Benzodiazepine 24-48 hours 1 week 
Cocaine 12-24 hours 2-3 days 
 
Procedures for extraction of drugs of abuse from biological samples:  
The liquid - liquid extraction (LLS): the method used for emergency analysis and for unknown analysis 
when substances with physico-chemical properties must be extracted. This process facilitates the 
extraction of a drug from aqueous solutions in organic solvents and involves a relatively high 
consumption of solvents and multiple operations of extraction and separation. 
Solid phase extraction (SPE): the aim of this method is the extraction, purification, and, sometimes, the 
concentration of non-volatile or semi-volatile substances for analysis. It involves passing aqueous 
solution through a column with silica based desiccant, active carbon and resins. It is a more expensive 
process and often less sensitive (25- 29). 
Testing of substances of abuse extracted from biological samples  
The tests for substances of abuse shall be sub-divided into two types of analytical procedures:  
- Screening tests: are quick, simple and requires a minimum previous processing of the sample. 
Examples: immunoassays, Thin Layer Chromatography (TLC).  
- Confirmatory tests: are performant, sensitive, selective methods that reduce the number of false-
positive / false-negative results. Examples: Gas Chromatography-Mass Spectrometry (GCMS), 
High performance liquid chromatography (HPLC), Liquid chromatography-Mass Spectrometry 
(LCMS). 
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1. Screening methods for the determination of drugs of abuse: thin layer chromatography, 
immunoassay 
For the toxicological screening of drugs of abuse simple, quick and inexpensive analytical methods 
are required. Screening methods plays an important role in the forensic medicine laboratories, both in 
the analysis of incriminated objects as well as in the analysis of biological samples. Due to the large 
diversity of samples it is practically impossible to use extraction methods and sophisticated and time-
consuming instrumental techniques for analysis of all samples. Therefore, it is absolutely necessary to 
use simple screening tests to restrict further research area (30- 33). 
The conditions that have to be met by a method of analysis to be used as screening test:  
- easy to performed 
- quick  
- not require a complicated and unaffordable equipment 
- require few usual reagents  
- not require highly qualified personnel 
- inexpensive 
- able to be performed also outside a lab 
- require a minimum processing of the samples. 
The interpretation of screening tests results is a complex process, which requires an overview on 
limitations raised by the analysis method, by pharmacokinetic and biotransformation characteristics of 
the incriminated substance, but also by psychological, physiological and pathological pattern of the 
patient (including history of drug dependence) (34). A negative result does not necessarily indicate the 
absence of the substance, that can be present but at a level below the detection limit of the method. A 
true-positive result from a screening test will not indicate the dose, the time or the route of 
administration, and it doesn’t make the difference between an occasional or a chronic administration.  
That’s why, it is recommended to use more specific and performant analytical methods for confirming 
the screening test results (35- 38). 
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Screening tests are used in several purposes: forensic (analysis of incriminated samples), clinical or 
medical care (admission in substitution treatment, compliance of treatment, testing abstinence during 
therapy), occupational medicine, doping tests. The most commonly used screening tests at the present 
time are thin-layer chromatography (TLC) and immunoassays. 
Thin-layer chromatography (TLC) is a wide spread technique used for the separation and 
identification of substances. It is used to analyse bulk active substances, pharmaceutical products, but 
also illicit substances or biological samples. Conventional TLC is a fast and low-cost method for 
qualitative analysis. Requires a minimum and readily available equipment, and experimental techniques 
are easily acquired. These determinations are not expensive, and can be carried out in laboratories with 
limited facilities (39- 42). 
The Committee of Systematic Toxicological Examination of the International Association of 
Forensic Toxicologists (TIAFT), recommends 10 separation systems to identify medicinal substances 
and drugs of abuse, depending on their acid-base character. The correspondence between the different 
psycho-active substances and TIAFT recommended systems is shown in table number 5. 
 
Table 5. TLC methods for the analysis of psycho-active substances according to TIAFT 
Drug of abuse TA TB TC TE TL TAE TAF TAJ TAK TAL 
5-methyltryptamine 56 - - - - - - - - - 
amphetamine 43 20 9 43 18 12 75 - - - 
benzphetamine 73 67 70 87 70 60 - - - - 
benzoylecgonine 21 0 1 - - - - - - - 
cannabidiol 94 - - 95 - - - 88 76 97 
cannabinol 94 - - 95 - - - 90 77 97 
cocaine 65 45 47 77 54 35 30 13 0 2 
9- THC 11 - - 31 - - - 0 1 31 
diamorphine 47 15 38 49 4 26 33 25 5 64 
dimethyltryptamine 46 15 10 63 11 14 56 2 3 41 
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dimethyltryptamine 40 9 9 50 6 14 39 - - - 
DOM 51 15 17 41 16 9 76 - - - 
ketamine 63 37 63 79 64 68 72 47 4 43 
lysergic acid 58 0 0 0 0 70 16 48 7 79 
mescaline 20 3 10 24 12 6 63 2 9 51 
methamphetamine 31 28 13 42 5 9 63 0 3 45 
methadone 48 59 20 77 27 16 60 8 0 45 
morphine 37 0 9 20 1 18 23 0 0 15 
psilocin 39 5 9 47 9 14 48 - - - 
psilocybin 5 0 - 0 0 80 1 - - - 
 
Immunoassays are commonly used as screening tests for testing drugs of abuse. Often, they are 
not making any discrimination between the related compounds, so the results obtained are likely to be 
cross-reactive. For this reason, such methods are followed by confirmation using performant separation 
technique such as GC-MS for qualitative analysis and HPLC for quantitative analysis. 
Used on a larger scale, the immunoassays methods are based on the antigen - antibody reaction. The 
quality of antibody is critical for the sensitivity, precision and accuracy of the determination. In order to 
generate a measurable signal, the immunoassay technique uses a specific antibody for the identified 
compound or class of compounds and a labelled form of the same compound or the antibody. The 
labelling may be done with a radioisotope in case of radioimmunoassay (RIA), an active enzyme in case 
of enzyme-linked immunosorbent assay (ELISA) or a fluorescent compound in case of fluorescence 
immunoassay (FIAS) (43- 46). Polarization Immunoassay (FPIA) use fluorescein attached to one 
compound (antigen) as marker. When it is bound to antibody, fluorescein molecular rotation slows down 
and leads to changes in the polarization of fluorescent emission. The polarization p is inversely 
proportional to the concentration of the unbound compound. The main advantage is the exceptional 
stability of the FPIA reagents, which enable the tracing of the calibration curve valid for longer time and 
the automation of the determination (47). 
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In the immunoassay methods, the biological sample requires a minimum previous preparation 
(e.g. simple centrifugation in the case of urine). After the initial immunoassay test of the screening 
program, usually we proceed to identify the particular compound involved using performant separation 
methods from complex matrices as biological samples (48- 50). 
2. Toxicological examination of the drugs of abuse - confirmatory methods 
In order to eliminate false positive or false negative screening tests, toxicological analysis is continued 
with confirmatory tests. 
Confirmatory tests: 
- Are effective methods, sensitive, selective, accurate, reproducible; 
- Are performant column chromatographic methods: GC-MS, HPLC, LC-MS; 
- Requires a laborious sample preparation stage;  
- Requires expensive equipment and highly qualified personnel; 
- Are analysed with higher costs. 
Chromatography is a method of separating components of a mixture on the basis of their different 
distribution between two phases, one of which is stationary - generally fixed on a support (glass or 
aluminium plate, paper sheet, steel column, etc.) and other, mobile, which moves in relation to the fixed 
phase. This conducted to a different migration of the components leading to their separation. The mobile 
phase is gas in GC-MS methods and liquid in HPLC and LC-MS methods. The chromatography is used 
both for qualitative and quantitative determination of the chemical substances. The identification is 
based on the time required for the migration of the substance into the separation system. The assay is 
based on the proportionality of the amount to the peak area (51). 
Confirmatory Tests - gas chromatography coupled with mass spectrometry (GC-MS) 
The GC-MS is the gold standard for a reliable identification of the drugs of abuse in all kinds of 
samples. It combines the advantages of gas chromatography with those of mass-spectrometry. Mass 
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spectrometry is an analytical technique used to identify organic substances, based on pattern 
recognition's of fragments resulting from the ionization. 
Table 6. GC-MS methods for heroin and its metabolites analysis in biological samples 
References United Nations 
International 
Drug Control 
Programme 
Goldberger B. A. 
et al. 
 
De Giovanni N. et al. 
 
Wang W.L. et al. 
 
Detected 
compounds 
Drugs of abuse Heroin, 6-acetyl 
morphine 
Heroin, cocaine and 
metabolites 
Cocaine, morphine, 
codeine, heroin and 
metabolites 
Column Diffrent capillary 
colum 12 m x 0,2 
mm d.i.  
Rtx-5, 15m x 25 
mm d.i.  
HP-1, 12 m x 0,2 mm 
d.i. 
HP-1, 12 m x 0,2 mm 
d.i., film de 0,33 μm 
Carrier gas He He ultrapur  He 
Flow rate 1,9 mL/min 1,2 mL/min  1 mL/min 
Injection type  splitless  splitless 
Injector 
temperature 
250°C 250 °C 250 °C 250 °C 
Oven 
temperature 
150 – 300 °C, 
with gradient of 
12 °C/min 
1 min. to 150 °C, 
followed by 
increasing to 200 °C 
with a gradient of 
12.5 °C / min, 
maintained at 200 
°C for 15 s, 
increasing to 290 °C 
with 30 °C/min, 
held for 4 min 
120 °C for 1 min, 
increasing to 220 °C 
with a gradient of 20 °C 
/ min, then to 260 °C 
with 5 °C / min and 
finally to 280 ° C with a 
20 ° C / min, held for 2 
min 
70 °  for 1 min, 
increasing to 220 °C 
with a gradient of 35 °C 
/ min, constant at 220 
°C 0.25 min, increasing 
to 250 °C at 10 °C / 
min, held at 250 ° C for 
3 min 
Derivatization SIM or TFA - BSTFA -1%TMCS - 
Observation guide of 
recommended 
methods for 
analysing 
substances of 
abuse 
Heroin: LOD 10 
μg/L; range 1,0 – 
250 μg/L, r 0,995 
6-acetyl morphine: 
LOD 1,0 μg/L, 
range 1,0 – 500 
μg/L, r >0,995 
LOD 50 ng/mL; range 
50-500 ng/mL 
Hair: range 0,1 – 10,0 
ng/mg 
Urine, saliva, plasma: 
range 1 – 100 ng/mL 
Extraction Liquid-liquid 
extraction or SPE 
with C18 
cartridge  
 
SPE with 
ZSDAU020 
cartridge 
SPE with C18 cartridge SPE 
Biological 
samples 
Blood, saliva and 
urine 
Blood, plasma, 
saliva and urine 
Urine Blood, saliva, urine and 
hair 
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The mass spectrum recorded is compared with libraries of mass spectrum. In table number 6 are 
listed a few GC-MS methods for heroin and its metabolites analysis in biological samples. 
Confirmatory Tests – High Performance Liquid Chromatography (HPLC) 
HPLC method is the first choise for the quantitative determination of drugs of abuse in all kinds of 
samples. Quantitative determination is based on proportionality between peak area and amount of the 
analyte in the sample. In Table number 7 several HPLC methods for analysis of the heroin and its 
metabolites in biological samples are presented (52). 
Table 7. HPLC methods for analysis of the heroin and its metabolites in biological samples 
 United 
Nations 
International 
Drug Control 
Programme 
United Nations 
International 
Drug Control 
Programme 
Katagi M. et al. Bourquin D. et al. Low A.S. et al. Umans  J. 
G. et al. 
Detected 
compound
s 
  Heroin and metabolites 
(monoacetylmorphinae, 
diacetylmorphine) 
Heroin, morphine, 
codeine and their 
metabolites 
Heroin, 6-
monoacetyl-
morphine, 
codeine, 
pholcodine, 
dihydrocodeine, 
morphine 
Heroin, 6-
monoacetyl
-morphine, 
morphine 
Detection UV, λ=218nm Electrochemical Mass spectrometry  DAD, λ=210 nm UV, λ=280 nm UV, λ=218 
nm 
Column LiChrosorb 
60, 5 μm, 
30cm x 4 mm 
d.i. 
ODS, 5μm, 25 
cm x 4,6 mm d.i. 
Capcell Pak SCX 1,5 
mm d.i. x 150 mm, 5 μm 
 
C18, 125 x 2 mm 
d.i., 3 μm 
Hypersil 3μm, 
200 x 2 mm d.i. 
LiChrosorb 
Si 60 5μm, 
30 x 4 mm 
d.i.,  
Faza 
mobilă 
acetonitril e: 
ammonia: 
methanol: 
acetic glacial 
acid soluţia 
B  
acetonitrile - 
0.2M sodium 
perchlorate 
buffer / 0.005 M 
sodium citrate 
(1: 9, v / v) 
10 mM ammonium 
acetate (pH 6.0) - 
acetonitrile (30:70, v / v) 
o-phosphoric acid, 
dicyclohexylamine, 
acetonitrile, water, 
dichloromethane, 
pentane, 
methanol, 
diethylamine 
acetonitrile, 
ethanol 
concentrate
d ammonia, 
methanol, 
glacial 
acetic acid 
Elution Izocratic  Izocratic Izocratic Gradient Izocratic Izocratic 
Flow rate 1,3 mL/min 1,9 mL/min  0.2 mL/min 0,4 mL/min 80 mL/ora 
(1.33 
mL/min) 
Extracţie LLE or SPE 
with C-18 
cartridge 
LLE or SPE 
with C-18 
cartridge 
SPE  ex SPE with C-18 
cartridge  
SPE with C-18 
cartridge 
LLE 
Biological 
samples 
Blood, saliva 
and urine 
Blood, saliva 
and urine 
Urine PLasma Urine Blood 
 
Confirmation Tests - liquid chromatography coupled with mass spectrometry (LC-MS) 
Liquid chromatography coupled with mass spectrometry is a modern hyphenated technique which 
combines the advantages of HPLC with those of mass-spectrometry. The mass spectrum recorded is 
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compared with libraries of mass spectrum. It is used for both qualitative and quantitative determination, 
having as advantages the selectivity and the increased sensitivity (53). 
In table number 8 a few LC-MS methods for analysis of the methadone and its metabolites in biological 
samples are listed (54). 
Table 8. LC-MS methods for methadone and its metabolites determination in biological samples 
References Vlase L. et 
al. 
Dams R. et 
al. 
Danielson T.J. 
et al. 
Widschwendter 
C. G. et al. 
Kelly T. et al.  Rosas M.E. et al. 
Detected 
compounds 
Methadone Opioids, 
cocaine and 
metabolites 
Methadone and 
her metabolites 
(EDDP, 
EMDP) 
Methadone and 
quetiapine 
Enantiomers 
of the 
methadone 
and of  
EDDP, 
EMDP 
Enantiomers of the 
methadone and of 
EDDP 
Detection MRM (310 
→  265) 
SRM MRM  MRM (m/z 310 
→ 265; 384 →  
253) 
MRM SIM (m/z 310, 278, 
313, 281) 
Ionization ESI API  ? API API ESI 
Column Zorbax SB-
C18 (100 x 
3.0 mm, 3.5 
μm I.D.) 
Synergi Polar 
RP (150 x 2 
mm, 4 μm) 
 ? Waters 
Acquity, C18 
(50 x 2,1 mm, 
1,7 μm)  
AGP alpha-
glicopro-tein 
AGP alpha- 
glicopro-tein 
Internal 
standard 
- Deuterated 
isotopes  of 
the analysed 
compounds 
Deuterated 
isotopes  of the 
analysed 
compounds 
D3-methadone - D3-methadone and 
D3-EDDP 
Mobile phase Acetonitrile: 
0.2% formic 
acid 45:55 
(v/v) 
Mixture of 10 
mM 
ammonium 
formate or 
0.001% 
formic acid 
and 
acetonitrilein 
various 
proportions 
  Mixture of 
acetonitrile and 
5 mM formic 
acid  
20 mM acetic 
acid: 
isopropanol 
93: 7 (v/v) 
Acetonitrile: 
ammonium acetate 
buffer 18:82 (v/v) 
 
Elution isochratic gradient   gradient isochratic isochratic 
Flow rate 1 mL/min 300 μL/min   0,25 mL/min 0,9 mL/min 0,9 mL/min 
Column 
temperature 
45ºC 25ºC - - - 25ºC 
Extraction De-
proteinized 
plasma with 
methanol 
Urine diluted 
with water  
Without  ? With 
acetonitrile and 
centrifugation 
 ?  ? 
Biological 
samples 
Plasma 
Urine 
Urine Blood  
Liver 
Urine Hair Saliva 
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Conclusions 
The methodology of a toxicological analysis of the substances of abuse shall be developed on the 
basis of: test sample type, analysis purpose, pharmacokinetic and biotransformation particularities of 
substance, equipment and reagents available, stuff expertise, cost.  
Immunoassays offers a flexible approach of the analyses of drugs of abuse from different 
biological samples and represents a convenient method and a quick screening test for a large number of 
samples, with different matrixes. A true-positive result of an initial screening test, will not indicate on its 
own the dose, the time or the route of administration and it will not make the difference between an 
occasional administration or a chronic one.  
Screening tests require subsequently performing confirmation tests for removing false positiveâ/ 
false negative results. Confirmation tests are modern chromatographic techniques (GC-MS, HPLC, LC-
MS), high-performance, sensitive, selective, accurate. Confirmation tests have as disadvantages: time-
consuming step for the processing of the samples, expensive equipment, highly qualified staff and high 
cost. 
The identification and the assay of drugs of abuse and their metabolites in biological samples 
provides to the specialists (doctors, authorities in the field of health, representatives of law) an objective 
tool for the diagnostic of abuse or for the monitoring of addictions treatment. Interpretation of the results 
is a complex process and requires an overview of: the analysis method, pharmacokinetic and 
biotransformation particularities of the substance, clinical pattern of the patient (including history of 
drug dependence). 
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